Stock Details
BAYZF is Bayer Aktiengesellschaft's stock. Stock exchange Other OTC (Currency USD). Average price in 50 days is 51.76$. Average daily volumn in 3 months 13.24k. Market cap 55.40B



Stock symbol : BAYZF. Exchange : Other OTC. Currency : USD
Lastest price : 56.39$. Total volume : 11.25k. Market state REGULAR
Click reload if you want to check the lastest price on market!!!

Bayer Aktiengesellschaft (BAYZF)
Last Price
56.39$
Change
0.00
Volume
11.25k

Previous Close56.39
Open56.45
Day Range56.39-56.39
Bid0.00 x N/A
Ask0.00 x N/A
Volume11.25k
Average Volume13.24k
Market Cap55.4B
Beta1.10
52 Week Range45.99-74.34
Trailing P/E12.39
Foward P/EN/A
Dividend (Yield %)3.63%
Ex-Dividend Date2022-05-02



Financial Details



Organization

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescr... iption over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

Market Cap:
55.40B
Revenue:
44.08B
Total Assets:
120.24B
Total Cash:
4.56B


News about "Bayer Aktiengesellschaft"

Bayer Aktiengesellschaft (BAYRY) Upgraded to Buy: Here's Why

Source from : MSN - 1 month ago

Earnings Estimate Revisions for Bayer Aktiengesellschaft For the fiscal year ending December 2022, this company is expected to earn $2.02 per share, which is a change of 4.7% from the year-ago ...See details»


bayer-sustainability-stakeholder-engagement-image

Bayer: Sustainability Stakeholder Engagement

Source from : Yahoo - 8 hours ago

In September 2015, the United Nations (UN) adopted "Agenda 2030," setting a total of 17 Sustainable Development Goals (SDGs).See details»


Why Bayer Aktiengesellschaft (BAYRY) is a Top Value Stock for the Long-Term

Source from : Nasdaq - 13 days ago

Headquartered in Leverkusen, Germany, Bayer AG is a life science company with core competencies in the areas of health care and agriculture. BAYRY is a #3 (Hold) on the Zacks Rank, with a VGM ...See details»


Bayer Aktiengesellschaft 2022 Q3 - Results - Earnings Call Presentation

Source from : Seeking Alpha - 28 days ago

Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site ...See details»


bayer-launches-industry-first-public-database-listing-companys-science-collaborations-and-partnerships-in-the-us-image

Bayer Launches Industry-First Public Database Listing Companyโ€™s Science Collaborations and Partnerships in the U.S.

Source from : YAHOO!Finance - 10 hours ago

Today, Bayer announced the U.S. launch of the Bayer Science Collaboration Explorer (BSCE) as part of its ongoing efforts to enhance public trust in scientific innovations, processes, and R&D ...See details»


Bayer Aktiengesellschaft Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Source from : Yahoo! Sports - 25 days ago

Last week, you might have seen that Bayer Aktiengesellschaft (ETR:BAYN) released its third-quarter result to the market. The early response was not positive, with shares down 3.1% to โ‚ฌ51.41 in ...See details»


While institutions own 42% of Bayer Aktiengesellschaft (ETR:BAYN), individual investors are its largest shareholders with 58% ownership

Source from : Yahoo! Sports - 29 days ago

Every investor in Bayer Aktiengesellschaft (ETR:BAYN) should be aware of the most powerful shareholder groups. With 58% stake, individual investors possess the maximum shares in the company.See details»


Bayer AG (BAYZF) Q3 2022 Earnings Call Transcript

Source from : Seeking Alpha - 28 days ago

[Operator Instructions]. I would now like to hand the conference over to Oliver Maier, Head of Investor Relations of Bayer AG. Please go ahead. Great. Thank you so much, Heidi. Good afternoon ...See details»


Bayer Confirms 2022 Objectives After 3Q Sales Beat

Source from : Morningstar%2c Inc. - 28 days ago

Bayer AG on Tuesday backed its 2022 financial objectives after third-quarter sales beat expectations and it reported earnings growth in all its segments. The German pharmaceutical-and-agricultural ...See details»


Bayer estimates new GM soybean to reach 10% of Brazil's 2022/23 planting area

Source from : Reuters - 22 days ago

REUTERS/Henry Romero/File Photo SAO PAULO, Nov 14 (Reuters) - Bayer AG's (BAYGn.DE) agriculture unit in Brazil expects that its new genetically modified (GM) soybean Intacta2 Xtend will account ...See details»


Bayer Profit Boosted by Demand for Seeds and Weed Killer

Source from : Bloomberg L.P. - 28 days ago

Bayer AG posted earnings that narrowly topped estimates amid sustained demand for agricultural seeds and chemicals including the controversial weedkiller Roundup. The German company recorded core ...See details»


Bayer AG feels spillover effects from import fair

Source from : ไธญๅ›ฝๆ—ฅๆŠฅ็ฝ‘ - 19 days ago

[ZHU XINGXIN/CHINA DAILY] As an old friend of the just-concluded China International Import Expo, German agricultural and healthcare group Bayer AG said that its business benefits from the expo ...See details»


Bayer officials break ground on $43.6 million expansion project to Myerstown facility

Source from : YAHOO!News - 5 days ago

The expansion will increase packaging and production areas by 70,000 square feet and include eight packaging lines, according to officials.See details»


bayer-celebrates-60-years-in-the-philippines-with-php750m-integrated-office-in-manila-image

Bayer celebrates 60 years in the Philippines with PHP750M integrated office in Manila

Source from : Philippine Daily Inquirer - 13 days ago

Bayer officially opened its brand-new PHP 750-million office in the Philippines as it commemorates its 60 years of advancing health and nutrition in the country.ย  Located at Science Hub Tower 1 at ...See details»